Brittany Bohinc Henderson, MD, ECNU, Endocrinology & Metabolism, Wake Forest Baptist Health, discusses new discoveries in insulin and incretin therapies for diabetes. These include Tresiba® insulin degludec injection, Toujeo® insulin glargine injection, Humulin R U500® Kwikpen, Afrezza® inhaled insulin, DPP-4 inhibitors and GLP1 agonists.
Related Videos